Horizon Pharma: Rayos FDA Approval Thursday Seems Likely

Perhaps the biggest risk to Horizon going into tomorrow’s FDA approval decision is the stock’s run from $4 to $7.50 over the past six weeks. That’s a big move ahead of a major catalyst and can often lead to a significant sell off once Rayos’ approva…

 
  Your Reaction?
 

    Hot Buzz

    These Are The Victims Of The Washington Mall Shooting

    Labour Friends Of Israel Activist Reports Anti-Semitic Incident On First Day Of Party&#...

    Now Buzzing